Clinical Trial

Remote Alert Pathway To Optimize CaRe of Cardiac Implantable Electrical Devices: The RAPTOR-CIED Study (Main Phase)

Study acronym: RAPTOR - MAIN
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
he Remote Alert Pathway to Optimize Care of Cardiac Implantable Electrical Devices (RAPTOR-CIED) Study is a pragmatic, multi-center, randomized trial with 1:1 patient-level randomization comparing the safety and effectiveness of alert-driven care versus guideline-based care for patients with wireless cardiac implantable electrical devices (CIEDs). The study will be conducted in 2 phases: a Feasibility Phase and a Main Phase. This registration outlines the goals and design features of the Main Phase of the study.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-01-12.
Trial Details
NCT Number NCT07352657
Lead Sponsor Beth Israel Deaconess Medical Center
Collaborators: Patient-Centered Outcomes Research Institute
Conditions Pacemaker, Implantable Defibrillator
Enrollment 3,000 participants
Start Date 2026-12-01
Primary Completion 2030-12-31 (estimated)
Study Completion 2031-01-31 (estimated)
Updated on ClinicalTrials.gov 2026-02-06